liensinine

Liensinine is a naturally occurring **bisbenzylisoquinoline alkaloid** isolated primarily from the seed embryo of *Nelumbo nucifera* and studied as a **small-molecule** bioactive compound rather than an approved pharmaceutical product. Preclinical literature describes pleiotropic pharmacology including effects on **pancreatic beta-cell function**, **gut microbiota composition**, inflammatory and oxidative-stress pathways, autophagy, and apoptosis-related signaling. In the provided 2025 publication context, liensinine was investigated for **type 2 diabetes mellitus**, where it was reported to lower glucose and improve beta-cell function with associated modulation of microbial metabolites such as short-chain fatty acids; however, there is no clear evidence from the provided data that it has an established commercial developer, manufacturer, approved indication, or a validated single canonical therapeutic target.

Other names

liensinine